← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS

NDA · New Drug Application · Sponsor: MATRIX LABS · Approved 2010-07-08

Drug application

FDA Application #

NDA200793

Application type

New Drug Application

Brand name

LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS

Generic name

Lamivudine

Active ingredients

Lamivudine; Nevirapine; Zidovudine

Dosage form

TABLET, FOR SUSPENSION

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

MATRIX LABS

First approval

2010-07-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown